1 / 15

The Thalassaemias

The Thalassaemias. Thalassemias- group of disorders in which normal Hb prodution is partially or completely suppressed and is charaterised by- reduced output of one or more of the chains secondary to mutation of globin genes .

Download Presentation

The Thalassaemias

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The Thalassaemias Thalassemias- group of disorders in which normal Hb prodution is partially or completely suppressed and is charaterised by- reduced output of one or more of the chains secondary to mutation of globin genes. They are classified according to the particular globin chain that is ineffectively produced– the  and  thalassaemias are by far the most important ↓ .

  2. Haemoglobin types involved- HbA - 2 2 HbA2 - 2 2 HbF - 2 2 HbH - 4 Hb Bart 4

  3.  thalassaemia • Thalassaemia is associated with a wide spectrum of clinical severity. •  thalassaemia results from over 150 different mutations of  globin genes resulting in absence or reduction of the  globin chain and excess production of  chain. This results in destruction of the red cell precursors in the reticuloendo-thelial system causing severe anaemia (-thalassaemia major)

  4. -Thalassaemia minor/TRAIT • thalassaemia minor or trait (heterozygous state): • This is a carrier state, and is usually asymptomatic. Mild, well-tolerated anaemia (Hb >9g/dL) which may worsen in pregnancy. • MCV <75fL, HbA2 >3.5%, slight HbF. Often confused with iron deficiency anaemia.

  5. Thalassaemia Intermediasyndrome • Thalassaemia Intermediasyndrome • between these two extreme (major and minor) • Describes an intermediate state with moderate anaemia .There may be splenomegaly. • 60% present at the age of 2 years

  6. Clinical features • -Thalassaemia major (60% present during infancy) • thalassaemia major (Cooley's anaemia) • Presents within the 1st year, with severe anaemia and failure to thrive. • Extramedullary haematopoiesis (production of RBCs outside the bone marrow) occurs in response to the anaemia, causing characteristic facial deformities eg skull bossing and hepatosplenomegaly (also due to haemolysis). • Skull x-ray shows ˜hair on end appearance due to increased marrow activity..

  7. skull bossing

  8. Thalassaemia intermedia syndrome (TIS) • Diagnostic features are variable, clinical manifestation of symptomatic anaemia, hepato-splenomegaly and bony changes – frontal bossing (haemolytic facies) occur after 2 years of age in contrast to -thalassaemia major which present during infancy. • Red cell indices, electrophoresis as in -thalassaemia major but haemoglobin level 6-8g/dl is maintained for a longer time. Transfusion required when Hb drops below 6g/dl

  9. DIAGNOSTIC FEATURES OF BETA-THALASSAEMIA Major • Profound hypochromic anaemia • Evidence of severe red cell dysplasia • Erythroblastosis • Absence or gross reduction of the amount of haemoglobin A • Raised levels of haemoglobin F • Evidence that both parents have thalassaemia minor

  10. Minor • Mild anaemia • Microcytic hypochromic erythrocytes (not iron-deficient) • Some target cells • Punctate basophilia • Raised resistance of erythrocytes to osmotic lysis • Raised haemoglobin A2 fraction • Evidence that one parent has thalassaemia minor

  11. Management of T.major • Blood transfusion: The management of severe forms of -Thalassaemia entails a regularblood transfusion • Iron chelation therapy with overnight infusions of desferrioxamine (DFO) and a low dose of vitamin C 200 mg/day to prevent life threatening complication of iron overload

  12. Regular transfusions to keep Hb>10 gm/dl is required. • Iron chelation therapy should be started when iron loading exceeds 1000 µg/dl

  13. MANAGEMENT contd… • Supportive care - Cholelithiasis with manifestation of cholestasis and cholangitis need cholecystectomy • Gene therapy - Correction of underlying defect in gene in stem cells by normal gene. • Bone marrow transplantation (BMT) - giving a new haemopoitic system is the only curative procedure.

  14. Splenectomy - isindicated in selected cases if hypersplenism present and there is no increase in Hb%inspite of blood transfusion. If it to be done prior Hib, pneumococcal and menigococcal vaccines are given. Prophylactic antibiotics should be given for life.

More Related